Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MannatechTrue DrinksGlucose HealthFSD PharmaHappiness Biotech Group
SymbolNASDAQ:MTEXOTCMKTS:TRUUOTCMKTS:GLUCNASDAQ:HUGENASDAQ:HAPP
Price Information
Current Price$20.52$0.01$4.08$1.94$2.00
52 Week RangeN/AN/AN/ABuyN/A
MarketRank™
Overall Score1.30.70.00.30.6
Analysis Score0.00.00.00.00.0
Community Score2.52.20.00.02.4
Dividend Score0.80.00.00.00.0
Ownership Score1.70.00.00.00.0
Earnings & Valuation Score1.31.30.01.30.6
Analyst Ratings
Consensus RecommendationN/AN/AN/ABuyN/A
Consensus Price TargetN/AN/AN/A$11.00N/A
% Upside from Price TargetN/AN/AN/A467.01% upsideN/A
Trade Information
Market Cap$42.46 million$40.78 million$47.49 million$37.17 million$51.80 million
Beta1.0910.93.541.390.6
Average Volume4,4821,007,70874,6243,830,1441,102,620
Sales & Book Value
Annual Revenue$157.73 million$1.95 million$290,000.00$190,000.00$65.06 million
Price / Sales0.2720.91163.75195.650.80
Cashflow$2.55 per shareN/AN/AN/A$0.49 per share
Price / Cash8.05N/AN/AN/A4.07
Book Value$11.43 per share($0.03) per shareN/A$5.15 per share$3.18 per share
Price / Book1.80-0.270.380.63
Profitability
Net Income$3.29 million$-3,880,000.00$-250,000.00$-39,200,000.00$12.69 million
EPSN/AN/AN/A($5.55)N/A
Trailing P/E Ratio6.311.100.00N/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins5.04%-255.80%-136.46%N/AN/A
Return on Equity (ROE)28.69%N/AN/A-111.76%N/A
Return on Assets (ROA)11.99%-165.86%-199.60%-92.92%N/A
Dividend
Annual Payout$0.64N/AN/AN/AN/A
Dividend Yield3.12%N/AN/AN/AN/A
Three-Year Dividend Growth14.00%N/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%N/AN/AN/AN/A
Current Ratio1.40%0.01%N/A2.62%N/A
Quick Ratio0.94%N/AN/A2.62%N/A
Ownership Information
Institutional Ownership Percentage14.97%N/AN/A0.73%1.57%
Insider Ownership Percentage45.80%18.18%N/AN/AN/A
Miscellaneous
Employees2141N/A17151
Shares Outstanding2.07 million4.97 billion11.63 million19.16 million25.90 million
Next Earnings Date5/11/2021 (Estimated)N/A5/12/2021 (Estimated)5/21/2021 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Bod’s first sales in US a precursor for further revenue generationBod’s first sales in US a precursor for further revenue generation
finfeed.com - April 6 at 9:26 PM
57 trillion squares, and other (non-April Fools) investments57 trillion squares, and other (non-April Fools) investments
maddyness.com - April 2 at 7:11 PM
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical OfficerCardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer
finance.yahoo.com - March 30 at 9:03 AM
Happiness Biotech Group Limited (NASDAQ:HAPP) Short Interest Up 102.4% in MarchHappiness Biotech Group Limited (NASDAQ:HAPP) Short Interest Up 102.4% in March
americanbankingnews.com - March 29 at 5:42 PM
Stocks that are likely to record significant movement on bourses todayStocks that are likely to record significant movement on bourses today
in.finance.yahoo.com - March 25 at 10:14 AM
Indias First Covid-19 Vaccine Covaxin Has No Serious Side EffectsIndia's First Covid-19 Vaccine 'Covaxin' Has No Serious Side Effects
medindia.net - March 12 at 10:36 AM
Covaxin has no serious side effects, says LancetCovaxin has no serious side effects, says Lancet
news.webindia123.com - March 11 at 8:55 AM
Covid-19: Covaxin demonstrates interim clinical efficacy of 81%Covid-19: Covaxin demonstrates interim clinical efficacy of 81%
khaleejtimes.com - March 5 at 10:02 AM
Chinese hackers target Indian Covid vaccine makers SII, Bharat Biotech: ReportChinese hackers target Indian Covid vaccine makers SII, Bharat Biotech: Report
khaleejtimes.com - March 3 at 1:14 PM
Sinovac is the best vaccine, only one we have now –PGH directorSinovac is the best vaccine, only one we have now –PGH director
gmanetwork.com - March 1 at 8:04 AM
What Do The Returns On Capital At Happiness Biotech Group (NASDAQ:HAPP) Tell Us?What Do The Returns On Capital At Happiness Biotech Group (NASDAQ:HAPP) Tell Us?
finance.yahoo.com - February 22 at 9:23 AM
Christian Angermayer’s Bionomics play and his obsession with magic mushrooms and MDMAChristian Angermayer’s Bionomics play and his obsession with magic mushrooms and MDMA
couriermail.com.au - February 19 at 8:55 AM
Happiness Biotech Provides Update and Guidance on Sales of Its E-Commerce BusinessHappiness Biotech Provides Update and Guidance on Sales of Its E-Commerce Business
finance.yahoo.com - February 17 at 8:55 AM
Happiness Biotech Launched Auto Sales Platform “Happy Auto”Happiness Biotech Launched Auto Sales Platform “Happy Auto”
apnews.com - February 3 at 9:11 AM
Happiness Biotech Launched Auto Sales Platform "Happy Auto"Happiness Biotech Launched Auto Sales Platform "Happy Auto"
finance.yahoo.com - February 2 at 8:55 AM
Covid-19 Vaccine Novavax is 89.3% EffectiveCovid-19 Vaccine Novavax is 89.3% Effective
medindia.net - January 31 at 5:14 PM
Glass Cases Fuels Up for a Brighter Future in "Chemicals"Glass Cases Fuels Up for a Brighter Future in "Chemicals"
westword.com - January 30 at 10:48 PM
Study Shows Why People Overuse AntibioticsStudy Shows Why People Overuse Antibiotics
medindia.net - January 30 at 5:44 PM
Indias Covaxin Neutralizes UK Variant of CovidIndia's Covaxin Neutralizes UK Variant of Covid
medindia.net - January 29 at 7:58 PM
New Covid strain: Indian vaccine likely effective against variantNew Covid strain: Indian vaccine likely effective against variant
khaleejtimes.com - January 28 at 6:09 PM
Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021
finance.yahoo.com - January 22 at 12:57 PM
Misinformation and Fear about COVID vaccinesMisinformation and Fear about COVID vaccines
newindianexpress.com - January 20 at 12:04 AM
WPD Pharmaceuticals Contracts Clinigen Clinical Supplies Management to Perform QP Certification of Berubicin for the Clinical Trials AuthorizationWPD Pharmaceuticals Contracts Clinigen Clinical Supplies Management to Perform QP Certification of Berubicin for the Clinical Trials Authorization
globalbankingandfinance.com - January 15 at 8:39 AM
India, Oman review ties, vow to step up trade and investmentIndia, Oman review ties, vow to step up trade and investment
thehindu.com - January 14 at 4:35 PM
Blue Matter Consulting LLCBlue Matter Consulting LLC
vault.com - January 13 at 8:27 PM
DateCompanyBrokerageAction
8/20/2020FSD PharmaBrookline Capital ManagementInitiated Coverage
12/6/2019Happiness Biotech GroupAegisInitiated Coverage
(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.